| P2093 | author name string | Ishida M | |
| | Katayama S | |
| | Harada K | |
| | Hori K | |
| | Kawasaki H | |
| | Kishimoto Y | |
| | Okubo M | |
| | Suyama A | |
| | Shiota G | |
| | Suou T | |
| P2860 | cites work | p53 mutations in human cancers | Q28302973 |
| | Ancient DNA: extraction, characterization, molecular cloning, and enzymatic amplification | Q28776625 |
| | Hepatocellular carcinoma: Recent progress | Q35227361 |
| | An Alu polymorphism intragenic to the TP53 gene | Q35802335 |
| | Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes | Q35976056 |
| | Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers | Q36954741 |
| | Low frequency of p53 mutations observed in a diverse collection of primary hepatocellular carcinomas | Q37246689 |
| | p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia | Q37535238 |
| | Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers | Q38480210 |
| | Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers | Q38487557 |
| | Histologic prognostic indicators in hepatocellular carcinoma | Q40265958 |
| | Clinical features and prognosis of hepatocellular carcinoma in Britain in relation to age. | Q40660165 |
| | Multifactorial analysis of p53 alteration in human cancer: a review | Q40736226 |
| | Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines | Q41675516 |
| | Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients | Q43850818 |
| | Prognostic significance of circulating P53 antibodies in patients undergoing surgery for locoregional breast cancer. | Q44540976 |
| | Factors affecting the prognosis of primary liver carcinoma | Q45008502 |
| | Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer | Q45263174 |
| | Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa | Q46754150 |
| | p53: a frequent target for genetic abnormalities in lung cancer. | Q52486321 |
| | Mutational hot spot in the p53 gene in human hepatocellular carcinomas | Q53499208 |
| | Primary hepatocellular carcinoma—etiology, pathogenesis, and prevention | Q53942854 |
| | Natural history of hepatocellular carcinoma in Spain | Q58022297 |
| | Mutations of the p53 Gene as a Predictor of Poor Prognosis in Patients With Non-Small-Cell Lung Cancer | Q58454765 |
| | Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism | Q67544701 |
| | P53 expression in breast cancer | Q68125248 |
| | p53 immunostaining as a marker of malignant disease in diagnostic cytopathology | Q68311408 |
| | Presence of circulating antibodies against cellular protein p53 in a notable proportion of children with B-cell lymphoma | Q68928820 |
| | Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil | Q69355883 |
| | Hepatic artery embolization in 120 patients with unresectable hepatoma | Q70150850 |
| | Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C | Q70823762 |
| | Des-gamma-carboxy prothrombin and proliferative activity of hepatocellular carcinoma | Q71696631 |
| | p53 protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutation | Q72114725 |
| | The natural history of hepatocellular carcinoma. A study of 100 untreated cases | Q72742215 |
| P433 | issue | 4 | |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 661-668 | |
| P577 | publication date | 1997-10-01 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma. | |
| P478 | volume | 27 | |